IL6 and neoplasm: Thus, salivary IL-6 mRNA is among the most effective and clinically important OSCC biomarker [16]. IL-6 promotes an immunosuppressive tumor environment by contributing to the expansion of derived suppressor cells and regulatory T cells, thereby inhibiting the antitumor immune response [17].